Recent study showed that sunitinib in combination with α-GITR could induce the significant infiltration of immune cells in tumor-metastatic liver, where the cell proliferation, activation and effector of CD8+ T cells and/or NK cells were extremely prominent [6]. The gene discussed is CD8A; the disease is neoplasm.